Stephanie Mehlis to Treatment Outcome
This is a "connection" page, showing publications Stephanie Mehlis has written about Treatment Outcome.
Connection Strength
0.053
-
Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study. J Eur Acad Dermatol Venereol. 2025 Jun; 39(6):1152-1162.
Score: 0.022
-
From laboratory to clinic: rationale for biologic therapy. Dermatol Clin. 2004 Oct; 22(4):371-7, vii-viii.
Score: 0.022
-
Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis. Br J Dermatol. 2011 Sep; 165(3):652-60.
Score: 0.009